MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

Novavax Inc

Închisă

SectorSănătate

5.97 -0.67

Rezumat

Modificarea prețului

24h

Curent

Minim

5.66

Maxim

6.22

Indicatori cheie

By Trading Economics

Venit

40M

-81M

Vânzări

3.8M

88M

EPS

-0.52

Marjă de profit

-91.755

Angajați

952

EBITDA

52M

-53M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+146.66% upside

Dividende

By Dow Jones

Următoarele câștiguri

9 mai 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-140M

1.1B

Deschiderea anterioară

6.64

Închiderea anterioară

5.97

Sentimentul știrilor

By Acuity

93%

7%

372 / 386 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bearish Evidence

Novavax Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

2 apr. 2025, 17:06 UTC

Principalele dinamici ale pieței

Novavax Falls But Then Recovers After WSJ Report on Vaccine's FDA Status

31 mar. 2025, 14:19 UTC

Principalele dinamici ale pieței

Vaccine Stocks Fall After Ousting of FDA's Vaccine Head

4 feb. 2025, 18:52 UTC

Principalele dinamici ale pieței

Psychedelic Drug Stocks Up, Vaccine Shares Down After Senate Committee Advances RFK Jr.

11 nov. 2024, 14:05 UTC

Principalele dinamici ale pieței

Novavax to Move Forward With Covid-19, Influenza Vaccine After FDA Lifts Clinical Hold

16 oct. 2024, 12:59 UTC

Principalele dinamici ale pieței

Novavax Says FDA Puts Clinical Hold on Covid-19, Flu Vaccines; Shares Drop

13 mai 2024, 18:14 UTC

Principalele dinamici ale pieței

Novavax Shares Pop Another 50% Following Sanofi Deal

10 mai 2024, 10:59 UTC

Principalele dinamici ale pieței

Novavax Shares Surge on $1.4 Billion Vaccine Licensing Deal with Sanofi

30 dec. 2024, 23:02 UTC

Achiziții, Fuziuni, Preluări

Novavax Completes Previously Announced $200M Sale of Czech Republic Manufacturing Site to Novo Nordisk

4 dec. 2024, 07:09 UTC

Achiziții, Fuziuni, Preluări

Novavax: Agreement to Close by Dec 30 >NVAX

4 dec. 2024, 07:08 UTC

Achiziții, Fuziuni, Preluări

Novavax: Sale Aligns With Plan to Become More Lean Organization, Drive Value From Pipeline Assets & Tech Platform >NVAX

4 dec. 2024, 07:07 UTC

Achiziții, Fuziuni, Preluări

Novavax: Deal to Also Reduce Annual Operating Costs by About $80M >NVAX

4 dec. 2024, 07:06 UTC

Achiziții, Fuziuni, Preluări

Novavax to Get $190M Cash Payment in 2024, Additional $10M in 2025 >NVAX

4 dec. 2024, 07:06 UTC

Achiziții, Fuziuni, Preluări

Novavax: Agreement Provides Company With Significant, Non-Dilutive Capital >NVAX

4 dec. 2024, 07:04 UTC

Achiziții, Fuziuni, Preluări

Novavax Announces Sale of Czech Republic Manufacturing Site to Novo Nordisk for $200M

15 nov. 2024, 13:34 UTC

Top știri

Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too -- WSJ

15 nov. 2024, 11:14 UTC

Market Talk

U.S. Vaccine Stocks Fall After Trump Picks Vaccine Skeptic RFK Jr as Health Department Head-- Market Talk

16 oct. 2024, 15:22 UTC

Câștiguri

These Stocks Are Moving the Most Today: ASML, Nvidia, Morgan Stanley, United Airlines, DJT, Novavax, J.B. Hunt, Cisco, and More -- Barrons.com

10 mai 2024, 20:11 UTC

Câștiguri

These Stocks Moved the Most Today: Novavax, Akamai, Sweetgreen, Taiwan Semi, Moderna, Gen Digital, JFrog, SoundHound, and More -- Barrons.com

10 mai 2024, 14:49 UTC

Câștiguri
Acțiuni populare

Stocks to Watch Friday: TSMC, Novavax, Nvidia -- WSJ

10 mai 2024, 10:47 UTC

Achiziții, Fuziuni, Preluări

Novavax Gets $1.4 Billion Deal With Sanofi. The Stock Jumps. -- Barrons.com

Comparație

Modificare preț

Novavax Inc Așteptări

Obiectiv de preț

By TipRanks

146.66% sus

Prognoză pe 12 luni

Medie 14.75 USD  146.66%

Maxim 19 USD

Minim 9 USD

În baza a 4 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruNovavax Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

4 ratings

2

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

N/A / 7.011Suport & Rezistență

Termen scurt

Strong Bearish Evidence

Termen mediu

Weak Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

372 / 386 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de scădere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Novavax Inc

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.